Low-Dose Baclofen Therapy

Introduction to Low-Dose Baclofen

The American Geriatrics Society recommends starting with lower doses of baclofen, particularly in older adults or those with renal impairment, due to increased risk of side effects such as sedation, dizziness, and mental clouding 3, 4
The American Association for the Study of Liver Diseases suggests that low-dose baclofen (30-60 mg per day) is effective in maintaining abstinence in patients with alcohol use disorder and liver cirrhosis 1, 2

Low-dose baclofen (30 mg daily) has shown efficacy in maintaining abstinence in patients with alcohol use disorder, according to the American Association for the Study of Liver Diseases 1, 2
The Journal of the American Geriatrics Society recommends considering low-dose baclofen for neuropathic pain, particularly trigeminal neuralgia, when other therapies have been refractory 3, 5

The American Geriatrics Society advises that elderly patients require lower starting doses of baclofen due to higher sensitivity to CNS effects 3, 4
The American Association for the Study of Liver Diseases recommends dose reduction in patients with renal impairment, as baclofen is primarily excreted by the kidneys 2
The American Association for the Study of Liver Diseases suggests that low doses are recommended in patients with hepatic disease, such as alcoholic liver disease 1, 2

A 12-week course of low-dose baclofen (10 mg three times daily) improved abstinence rates compared to placebo in patients with alcohol use disorder, according to the American Association for the Study of Liver Diseases 1
The therapeutic window of baclofen varies significantly between individuals, making careful titration from low doses essential, as recommended by the American Association for the Study of Liver Diseases 2